Endogenous Endophthalmitis - A Major Review.


Journal

Ocular immunology and inflammation
ISSN: 1744-5078
Titre abrégé: Ocul Immunol Inflamm
Pays: England
ID NLM: 9312169

Informations de publication

Date de publication:
Sep 2023
Historique:
medline: 7 9 2023
pubmed: 29 10 2022
entrez: 28 10 2022
Statut: ppublish

Résumé

Endogenous endophthalmitis (EE) is an uncommon but potentially devastating ocular infection involving the inner layers of the eye. The global incidence of EE is on the rise. Common ocular signs and symptoms associated with EE include conjunctival injection, ocular pain, and reduced visual acuity. On clinical examination, a history of prior or coexisting systemic infections, symptoms (e.g., fever, malaise), and localizing features may be noted. Clinical diagnosis is often challenging, resulting in critical delays that contribute to a poor prognosis. Blood cultures and ocular fluid samples can aid in conforming causative pathogen(s), after which empirical antibiotic therapy, both systemic and intravitreal, should be instated. The use of steroids to suppress inflammation remains controversial. Surgical options include pars plana vitrectomy. Overall prognosis varies depending on host and pathogen factors, and early diagnosis and initiation of appropriate treatment are crucial.

Identifiants

pubmed: 36306406
doi: 10.1080/09273948.2022.2126863
doi:

Substances chimiques

Anti-Bacterial Agents 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1362-1385

Auteurs

Cen Amy Xie (CA)

Department of Ophthalmology, Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore.

Jayanti Singh (J)

Department of Vitreo-retina and Uvea, Sadguru Netra Chikatsalaya, Chitrakoot, India.

Mudit Tyagi (M)

Department of Vitreo-retina, Anant Bajaj Retina Institute, LV Prasad Eye Institute, Hyderabad, India.

Sofia Androudi (S)

Department of Ophthalmology, University of Thessaly, Volos, Greece.

Vivek Pravin Dave (VP)

Department of Vitreo-retina, Anant Bajaj Retina Institute, LV Prasad Eye Institute, Hyderabad, India.

Atul Arora (A)

Advanced Eye Centre, Post-graduate Institute of Medical Education and Research (PGIMER), Chandigarh, India.

Vishali Gupta (V)

Advanced Eye Centre, Post-graduate Institute of Medical Education and Research (PGIMER), Chandigarh, India.

Rupesh Agrawal (R)

Department of Ophthalmology, Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore.
Department of Ophthalmology, National Healthcare Group Eye Institute, Tan Tock Seng Hospital, Singapore.
Eye ACP programme, Duke NUS Medical School, Singapore.
Ocular Infections and AntiMicrobials Group, Singapore Eye Research Institute, Singapore.

Helen Mi (H)

Department of Ophthalmology, Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore.
Department of Ophthalmology, National Healthcare Group Eye Institute, Tan Tock Seng Hospital, Singapore.

Alok Sen (A)

Department of Vitreo-retina and Uvea, Sadguru Netra Chikatsalaya, Chitrakoot, India.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH